December 08, 2020 Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19
December 07, 2020 Oncopeptides will host a webcast on Wednesday, December 9[th] at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting
December 07, 2020 Orexo Enters Exclusive License and Supply Agreement with Accord Healthcare for ZUBSOLV[® ]in Europe
December 06, 2020 Oncopeptides presents new data from phase 2 ANCHOR combination study in multiple myeloma at American Society of Hematology meeting ASH
December 01, 2020 Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin[®] in Diffuse Large B Cell Lymphoma
December 01, 2020 Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients
November 30, 2020 Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
November 30, 2020 Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)